VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

NCT00171132 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: valsartan
DRUG: atenolol
DRUG: hydrochlorothiazide

Sponsor

Novartis